Active substances
Neomycin + Polymyxin b
- SFDA 1
- US FDA 9
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| STATROL OPHTHALMIC OINTMENT | Eye ointment · Ocular use | 1 Tube | SAR 11.60 | NCE · Prescription | ALCON COUVREUR | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| NEOSPORIN G.U. IRRIGANT | EQ 800MG BASE/20ML;4,000,000 UNITS/20ML (EQ 40MG BASE/ML;200,000 UNITS/ML) | solution · irrigation | MONARCH PHARMS | Prescription | 28 Jun 1966 |
| NEOMYCIN AND POLYMYXIN B SULFATE | EQ 40MG BASE/ML;200,000 UNITS/ML | solution · irrigation | XGEN PHARMS | Prescription | 31 Jan 2006 |
| NEOMYCIN AND POLYMYXIN B SULFATE | EQ 40MG BASE/ML;200,000 UNITS/ML | solution · irrigation | XGEN PHARMS | Prescription | 31 Jan 2006 |
| NEOSPORIN G.U. IRRIGANT | EQ 40MG BASE/ML;200,000 UNITS/ML | solution · irrigation | MONARCH PHARMS | Discontinued | 28 Jun 1966 |
| STATROL | EQ 3.5MG BASE/GM;10,000 UNITS/GM | ointment · ophthalmic | ALCON | Discontinued | 12 Mar 1974 |
| STATROL | EQ 3.5MG BASE/ML;16,250 UNITS/ML | solution/drops · ophthalmic | ALCON | Discontinued | 12 Mar 1974 |
| STATROL | EQ 3.5MG BASE/ML;16,250 UNITS/ML | solution/drops · ophthalmic | ALCON | Discontinued | 30 Nov 1984 |
| NEOMYCIN AND POLYMYXIN B SULFATE | EQ 40MG BASE/ML;200,000 UNITS/ML | solution · irrigation | WATSON LABS | Discontinued | 8 Apr 1986 |
| NEOSPORIN | EQ 3.5MG BASE/GM;10,000 UNITS/GM | cream · topical | GLAXOSMITHKLINE | Discontinued |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.